Gerber Kawasaki Wealth & Investment Management Moderna, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$1.98 Billion
Q2 2024

A detailed history of Gerber Kawasaki Wealth & Investment Management transactions in Moderna, Inc. stock. As of the latest transaction made, Gerber Kawasaki Wealth & Investment Management holds 2,839 shares of MRNA stock, worth $186,664. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,839

Previous 3,231 12.13%

Holding current value

$186,664

Previous $344,000 2.03%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $39,674 - $65,311	-392 Reduced 12.13%	2,839 $337,000
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $8,707 - $11,774	102 Added 3.26%	3,231 $344,000
Q4 2023 Feb 12, 2024	BUY	$69.51 - $104.43 $278 - $417	4 Added 0.13%	3,129 $311,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $129,767 - $170,417	1,346 Added 75.66%	3,125 $322,000
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $461,202 - $624,782	-3,892 Reduced 68.63%	1,779 $216,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $400,875 - $582,194	-2,955 Reduced 34.26%	5,671 $870,000
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $198,878 - $352,867	-1,680 Reduced 16.3%	8,626 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $141,093 - $232,045	-1,195 Reduced 10.39%	10,306 $1.29 Million
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $70,043 - $105,600	598 Added 5.48%	11,501 $1.64 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $194,874 - $362,212	1,541 Added 16.46%	10,903 $1.89 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $2.07 Million - $3.38 Million	9,176 Added 4933.33%	9,362 $2.33 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $1.64 Million - $3.59 Million	-7,400 Reduced 97.55%	186 $186,000
Q2 2021 Aug 11, 2021	SELL	$129.91 - $234.98 $29,099 - $52,635	-224 Reduced 2.87%	7,586 $1.78 Million
Q1 2021 May 07, 2021	BUY	$109.18 - $185.98 $42,580 - $72,532	390 Added 5.26%	7,810 $1.02 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $4,273 - $11,040	65 Added 0.88%	7,420 $775,000
Q3 2020 Nov 02, 2020	SELL	$54.34 - $94.85 $14,345 - $25,040	-264 Reduced 3.47%	7,355 $520,000
Q2 2020 Aug 10, 2020	SELL	$29.67 - $80.0 $104,586 - $282,000	-3,525 Reduced 31.63%	7,619 $489,000
Q1 2020 May 05, 2020	BUY	$17.78 - $31.58 $198,140 - $351,927	11,144 New	11,144 $333,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account

Gerber Kawasaki Wealth & Investment Management Moderna, Inc. Transaction History